Latest price-to-book ratio
Summit Therapeutics Price-to-book ratio
Direct answer
Summit Therapeutics's price-to-book ratio is 19.31x.
The verified market snapshot reports 19.31x.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 27, 2026.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Price-to-book ratio
- 19.31x
Explore related company data
View Summit Therapeutics's market capitalizationView Summit Therapeutics's return on equityView Summit Therapeutics's dividend yieldView Summit Therapeutics's 52-week price rangeView Summit Therapeutics's profit marginView Summit Therapeutics's debt-to-equity ratioView all Summit Therapeutics key metricsReturn to Summit Therapeutics profile